Physician profile
Robert Baker
NPI 1013069699
$1,715.00
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $200 · 2021: $530 · 2022: $98.52 · 2023: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $666.44 | 2021-2023 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Boston Scientific Corporation | $317.28 | 2019-2020 | |
| Abbott Laboratories | $187.54 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $156.92 | 2019-2020 | |
| Lilly USA, LLC | $125.75 | 2019-2022 | |
| Daiichi Sankyo INC. | $105.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.88 | 2020-2023 | Relistor |
| Pfizer INC. | $41.13 | 2019 | |
| Pacira Therapeutics, INC. | $22.01 | 2019 | |
| Medtronic USA, INC. | $17.11 | 2019 | |
| Bioventus LLC | $16.63 | 2022 | |
| Grt US Holding, INC. | $14.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.